FO
INSM icon

FT Options’s Insmed INSM Stock Holding History

FT Options’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1K Buy
145,500
+37,900
+35% +$722K ﹤0.01% 218
2017
Q2 		$121K Buy
107,600
+22,600
+27% +$386K 0.21% 73
2017
Q1 		$91K Buy
+85,000
New +$1.31M 0.12% 119
2016
Q3 		– Sell
-30,000
Closed -$100K – 408
2016
Q2 		$100K Buy
+30,000
New +$350K 0.09% 151

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

FT Options's INSM Position: Q3 2017 in Review

FT Options reduced its Insmed (INSM) stake by 0.03% in Q3 2017, selling an estimated $95 and leaving 17,953 shares worth $560K. The position accounts for 0.84% of the portfolio, ranked #41.

FT Options first reported a position in INSM in Q1 2017 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold INSM as of Q3 2017.

  • FT Options held 17,953 shares of Insmed worth $560K as of Q3 2017.
  • FT Options sold 5 Insmed shares in Q3 2017, an estimated $95.
  • Insmed made up 0.84% of FT Options's portfolio in Q3 2017, its #41 holding.
  • FT Options first reported a position in Insmed in Q1 2017 and has held it in 3 quarters since.
  • 146 funds tracked by Wall St. Rank held Insmed as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.